Please login to the form below

Not currently logged in
Email:
Password:

Vesomni

This page shows the latest Vesomni news and features for those working in and with pharma, biotech and healthcare.

Astellas gets first OK for prostate drug Vesomni

Astellas gets first OK for prostate drug Vesomni

Astellas' new combination product for enlarged prostate problems in men has been approved in the Netherlands, its first market, under the Vesomni brand name. ... Vesomni (formerly known as EC905) is a once-daily, fixed-dose combination of the

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...
Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset...

Infographics